Emergent BioSolutions to Report Second Quarter 2025 Financial Results on August 6, 2025

About this update from Emergent Biosolutions Inc.

GAITHERSBURG, Md., July 15, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Wednesday, August 6, 2025, at 5:00 pm eastern time to discuss the financial results for the second quarter of 2025. Participants can access the conference call live via webcast and also by visiting the Investors page of Emergent’s website. To participate via telephone, please register in advance at this link . Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. A replay of the call can be accessed from the Investors page of Emergent’s website. About Emergent BioSolutions  At Emergent, our mission is to protect and save lives. For over 25 years, we’ve been at work preparing those entrusted with protecting public health. We deliver protective and life-saving solutions for health threats like smallpox, mpox, botulism, Ebola, anthrax and opioid overdose emergencies. To learn more about how we help prepare communities around the world for today’s health challenges and tomorrow’s threats, visit our  website  and follow us on  LinkedIn ,  X ,  Instagram ,  Apple Podcasts  and  Spotify . Investor Contact: Richard S. Lindahl Executive Vice President, CFO [email protected] Media Contact: Assal Hellmer Vice President, Communications [email protected]

View stock analysis, news, and events for Emergent Biosolutions Inc.